Bart holds an appointment as Associate Professor at the University Medical Center Groningen's Department of Nuclear Medicine and Molecular Imaging, and a guest appointment at the University of Oxford. Bart trained in analytical chemistry and radiochemistry at the Universities of Hasselt and Ghent, Belgium. He obtained his PhD in radiopharmaceutical sciences from the University of Ghent and spent several years at the University of Toronto as a post-doctoral fellow before joining the University of Oxford in 2007, and the University Medical Center in Groningen, the Netherlands, in 2021. His research focuses on radiolabelled compounds for imaging and radionuclide therapy of cancer. With our research team, we develop novel radiolabelled compounds for imaging hallmarks of cancer (e.g. DNA damage and repair) and investigate the (radio)biology of cancer cells treated with therapeutic radionuclides.